Literature DB >> 22249932

The B-cell superantigen Finegoldia magna protein L causes pulmonary inflammation by a mechanism dependent on MyD88 but not B cells or immunoglobulins.

Amy L Anderson1, Yi Zheng, Decheng Song, David Larosa, Nico Van Rooijen, Gerold Kierstein, Sonja Kierstein, Angela Haczku, Arnold I Levinson.   

Abstract

OBJECTIVE AND
DESIGN: To determine whether Finegoldia magna protein L (PL) causes lung inflammation and, if so, whether the response is dependent on its immunoglobulin (Ig)-binding B-cell superantigenic property. MATERIAL: Pulmonary inflammatory reactions were analyzed at various time points after intratracheal administration of PL to various strains of mice.
RESULTS: PL caused peribronchial and perivascular inflammation that peaked at 18-24 h. Polymorphonuclear cells (PMNs) began to accumulate in bronchoalveolar lavage fluid (BALF) of PL-challenged mice by 4 h and accounted for >90% of leukocytes by 18-24 h. Inflammation was marked by the appearance of MIP-2, KC, TNF-α, and IL-6 in the BALF with peak levels attained 4 h after PL administration. PL-induced pulmonary inflammation was associated with increased airway hyper-reactivity following inhalation of methacholine. The inflammatory reaction was unabated in mice lacking B cells and immunoglobulins. In contrast, PL-induced inflammation was abrogated in MyD88-deficient mice. PL-induced responses required alveolar macrophages.
CONCLUSIONS: These results strongly suggest that PL-induced lung inflammation is dependent on an innate MyD88-dependent pathway rather than the Ig-binding properties of this microbial B cell superantigen. We propose that this pulmonary inflammatory reaction is caused by the interaction of PL with a Toll-like receptor expressed on alveolar macrophages.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249932      PMCID: PMC3279619          DOI: 10.1007/s00011-012-0436-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  23 in total

1.  IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway.

Authors:  Kelly M Kroeger; Brandon M Sullivan; Richard M Locksley
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

2.  In vivo inflammatory response to a prototypic B cell superantigen: elicitation of an Arthus reaction by staphylococcal protein A.

Authors:  L M Kozlowski; W Li; M Goldschmidt; A I Levinson
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

3.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

Authors:  Jochen Schmitz; Alexander Owyang; Elizabeth Oldham; Yaoli Song; Erin Murphy; Terril K McClanahan; Gerard Zurawski; Mehrdad Moshrefi; Jinzhong Qin; Xiaoxia Li; Daniel M Gorman; J Fernando Bazan; Robert A Kastelein
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

4.  Pathogenesis of B-cell superantigen-induced immune complex-mediated inflammation.

Authors:  Amy L Anderson; Romeo Sporici; John Lambris; David Larosa; Arnold I Levinson
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation.

Authors:  Mariola Kurowska-Stolarska; Bartosz Stolarski; Peter Kewin; Grace Murphy; Christopher J Corrigan; Sun Ying; Nick Pitman; Ananda Mirchandani; Batika Rana; Nico van Rooijen; Malcolm Shepherd; Charlie McSharry; Iain B McInnes; Damo Xu; Foo Y Liew
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

6.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

Authors:  O Adachi; T Kawai; K Takeda; M Matsumoto; H Tsutsui; M Sakagami; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

7.  Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.

Authors:  Yuichi Kondo; Tomohiro Yoshimoto; Koubun Yasuda; Shizue Futatsugi-Yumikura; Mai Morimoto; Nobuki Hayashi; Tomoaki Hoshino; Jiro Fujimoto; Kenji Nakanishi
Journal:  Int Immunol       Date:  2008-04-29       Impact factor: 4.823

8.  Bacterial surface protein L binds and inactivates neutrophil proteins S100A8/A9.

Authors:  Bo Akerström; Lars Björck
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

9.  Essential role of IFNbeta and CD38 in TNFalpha-induced airway smooth muscle hyper-responsiveness.

Authors:  Deepika Jain; Stefan Keslacy; Omar Tliba; Yang Cao; Sonja Kierstein; Kunjlata Amin; Reynold A Panettieri; Angela Haczku; Yassine Amrani
Journal:  Immunobiology       Date:  2008-01-29       Impact factor: 3.144

10.  IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

Authors:  Mariola Kurowska-Stolarska; Pete Kewin; Grace Murphy; Remo C Russo; Bartosz Stolarski; Cristiana Couto Garcia; Mousa Komai-Koma; Nick Pitman; Yubin Li; Wanda Niedbala; Andrew N J McKenzie; Mauro M Teixeira; Foo Y Liew; Damo Xu
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.